Federal authorities are moving to drop a racial discrimination lawsuit against the Sheetz convenience store chain, part of a ...

0.65–0.89]; and 70–80 mm Hg diastolic BP TTR: 0.85 [95% CI, 0.80–0.90]), major adverse cardiovascular events (120–140 mm Hg SBP TTR: 0.76 [95% CI, 0.70–0.83]), and heart failure (110–130 mm Hg SBP TTR ...

Michael Dunlop achieved the extraordinary feat of winning his 30th TT in the Monster Energy Supersport TT on Monday at the ...

President Donald Trump’s deal to lower tariffs against China for 90 days is expected to spur a surge of pent-up cargo and further market volatility, according to experts. Trump has focused on ...

Acoramidis is a selective, small molecule, orally administered, near-complete (≥90%) TTR stabilizer. These findings further support the thesis that ever better increases in serum TTR lead to ...

Acoramidis is a selective, small molecule, orally administered, near-complete (≥90%) TTR stabilizer. These findings further support the thesis that ever better increases in serum TTR lead to ever ...

The results showed sustained reductions in serum TTR levels after a single dose, with a mean reduction of 90% by Day 28 and improvements in various clinical and biomarker measures over 24 months ...

Targeting of the 3′ untranslated region of TTR mRNA in primates resulted in 90% reduction of TTR at day 14 postinfusion and >70% reduction at day 28.102 A phase I study in mild–moderate ATTR-PN ...

Acoramidis is an oral small-molecule TTR stabiliser whose development is more than 90% complete. The ACT-EARLY trial aims to test whether prophylactic treatment of asymptomatic carriers of the variant ...

It may only be a 90-day reprieve from the steepest of President Donald Trump’s China tariffs, but it’s enough time to entice companies to restart factory operations and start shipping.

Acoramidis is a selective small molecule, orally administered near-complete (≥90%) transthyretin (TTR) stabilizer. ATTR-CM is a progressive fatal disease that presents as an infiltrative, restrictive ...

Acoramidis is a selective small molecule, orally administered near-complete (≥90%) transthyretin (TTR) stabilizer. ATTR-CM is a progressive fatal disease that presents as an infiltrative ...